cardinal health inc cah on thursday said it authorized a new 35 billion stock buyback program until the end of 2027 cardinal health said it expects 2024 adjusted profit of 645 to 670 a share compared to the wall street analyst estimate of 655 a share according to factset data the company also narrowed its 2023 adjusted profit guidance to 565 to 580 a share from 560 to 580 a share previously compared to analyst view of 573 a share cardinal health said it raised its longterm financial target for its pharmaceutical unit to 4 to 6 growth from its previous projection for lowsingle digit to midsingle digit growth cardinal health stock is up 83 in 2023 compared to an 112 rise by the sp 500 spx 